RCKT icon

Rocket Pharmaceuticals

146 hedge funds and large institutions have $1.85B invested in Rocket Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 55 increasing their positions, 49 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

less funds holding in top 10

Funds holding in top 10:

25% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 16

32% less capital invested

Capital invested by funds: $2.74B → $1.85B (-$888M)

Holders
146
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.68M
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$44.4M
2 +$24.1M
3 +$17.3M
4
NHAS
Novo Holdings A/S
Denmark
+$16M
5
Citadel Advisors
Citadel Advisors
Florida
+$15M

Top Sellers

1 -$39.8M
2 -$26.1M
3 -$15.5M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$14M
5
PA
Perceptive Advisors
New York
-$13.2M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$2.51M
52
$2.48M
53
$2.42M
54
$2.4M
55
$2.33M
56
$2.13M
57
$2.13M
58
$1.88M
59
$1.77M
60
$1.76M
61
$1.58M
62
$1.55M
63
$1.49M
64
$1.46M
65
$1.42M
66
$1.33M
67
$1.22M
68
$1.22M
69
$1.21M
70
$1.13M
71
$907K
72
$887K
73
$877K
74
$859K
75
$824K